Absci (ABSI) Cash from Operations (2020 - 2026)
Absci (ABSI) reported Cash from Operations of 26307000.0 for Q1 2026, down 20.46% on a YoY basis from 33073431.18 in Q1 2025, and up 9.85% sequentially from 29182000.0 in Q4 2025.
Absci (ABSI) Cash from Operations (2020 - 2026) Analysis & Trends
Absci (ABSI) has 7 years of Cash from Operations data on file, last reported at 26307000.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Operations fell 20.46% year-over-year to 26307000.0; the trailing twelve-month figure through Mar 2026 stood at 97393000.0 (down 27.51% YoY), and the FY2025 full-year result was 92925000.0, down 28.35% from the prior year.
- Cash from Operations grew to 26307000.0 in Q1 2026, from 29182000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 10361000.0 in Q3 2023 to a low of 29182000.0 in Q4 2025.
- A 5-year average of 19859352.94 and a median of 19234000.0 in 2023 frame the typical range for Cash from Operations.
- Across the five-year window, Cash from Operations plunged 190.31% in 2022 and soared 45.59% in 2023, its largest moves.
- Tracing ABSI's Cash from Operations over 5 years: stood at 18568000.0 in 2022, then gained by 19.64% to 14922000.0 in 2023, then retreated by 13.68% to 16964000.0 in 2024, then tumbled by 72.02% to 29182000.0 in 2025, then advanced by 9.85% to 26307000.0 in 2026.
- Business Quant data shows ABSI's Cash from Operations at 26307000.0 in Q1 2026, 29182000.0 in Q4 2025, and 25031000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.59 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 201.34 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.43 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.08 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.17 Mn |
| 10 | Absci | 1.23 Bn | 1.11 Bn | - | -26.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -26.31 Mn |
| Mar 31, 2026 | -26.31 Mn |
| Dec 31, 2025 | -29.18 Mn |
| Dec 31, 2025 | -29.18 Mn |
| Sep 30, 2025 | -25.03 Mn |
| Sep 30, 2025 | -25.03 Mn |
| Jun 30, 2025 | -16.87 Mn |
| Jun 30, 2025 | -16.87 Mn |
| Mar 31, 2025 | -21.84 Mn |
| Mar 31, 2025 | -21.84 Mn |
| Dec 31, 2024 | -16.96 Mn |
| Dec 31, 2024 | -16.96 Mn |
| Sep 30, 2024 | -20.73 Mn |
| Sep 30, 2024 | -20.73 Mn |
| Jun 30, 2024 | -16.84 Mn |
| Jun 30, 2024 | -16.84 Mn |
| Mar 31, 2024 | -17.86 Mn |
| Mar 31, 2024 | -17.86 Mn |
| Dec 31, 2023 | -14.92 Mn |
| Dec 31, 2023 | -14.92 Mn |